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See related article by Frenette et al., http://ccforum.com/content/18/6/602Large randomized trials such as the Albumin Italian
Outcome Sepsis (ALBIOS) trial involving 1,818 patients
with severe sepsis have revealed no evidence of acute
kidney injury (AKI) attributable to albumin infusion [1].
Such results are difficult to reconcile with an association
between albumin and AKI in the retrospective study by
Frenette and colleagues of 984 cardiac surgery patients re-
ceiving 6% hydroxyethyl starch 130/0.4, 10% pentastarch,
5% albumin and/or 25% albumin in unspecified combina-
tions [2]. Those investigators criticize the ALBIOS trial for
a lack of data on timing of AKI in relation to albumin
infusion, but that is also among the shortcomings of
their own study. Baseline data are not stratified by colloid
group, so imbalances cannot be assessed. The dose–
response analysis is univariate only. The propensity
matching did not include known independent risk factors
for AKI such as preoperative hypoalbuminemia [3] and* Correspondence: christian.wiedermann@asbz.it
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article, unless otherwise stated.cardiac catheterization [4]. Furthermore, the matching
failed to achieve satisfactory balance, since there remained
a significant difference in concomitant pentastarch
dose.
Frenette and colleagues misinterpret a study on the
robustness of propensity scores [5] as suggesting that their
study may have underestimated AKI risk associated with
albumin infusion. The study showed that mortality was
decreased by albumin in randomized trials of critically ill
patients with an odds ratio of 0.82 and a 95% confidence
interval of 0.67 to 1.00, but mortality was increased with
propensity score matching of observational study data
(odds ratio, 2.02; confidence interval, 1.43 to 2.84). The
difference was significant (ratio of odds ratio, 0.43; confi-
dence interval, 0.29 to 0.63). Thus, propensity scores
evidently cannot overcome the tendency to use albumin
as salvage treatment in sicker patients.d David R WilliamsonWe agree with Wiedermann and Wiedermann that
propensity scores will never replace randomized con-
trolled trials. However, the study design of the ALBIOS
trial differed from our study on several points [1]. In the
ALBIOS trial, albumin was administered to patients with
hypoalbuminemia and severe sepsis or shock according
to albumin levels, and not according to the clinical
context. In addition, the mean daily dose of albumin
administered was substantially lower in this randomized
trial (0.4 mg/kg/day over the first 7 days vs 0.9 mg/kg/
day in our study) and the period of administration was
much longer than our study (28 days vs 36 hours in our
study) [1,2]. The timing of AKI in relation to albuminadministration was not detailed in the ALBIOS trial,
while we summarized these results in a figure and in the
text.
Regarding our study, the unbalanced results from the
matching of our propensity score would have biased the
results toward a decreased AKI rate in the albumin
group. In addition, the percentage of patients under-
going cardiac catheterization was similar between the no
albumin and albumin groups in the propensity score
(27.0% vs 25.5%, P = 0.79). As mentioned, our study does
not provide a definitive answer on the use of albumin in
patients undergoing cardiac surgery. Future studies
should be performed on the use of albumin in surgical
populations.Abbreviations
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